Status:
COMPLETED
The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy
Lead Sponsor:
Chengdu University of Traditional Chinese Medicine
Collaborating Sponsors:
Massachusetts General Hospital
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This study evaluates the activation on prefrontal cortex with acupuncture and moxibustion for major depressive disorder.Half of participants will receive the treatment of acupuncture and moxibustion, ...
Detailed Description
Major depressive disorder (MDD) is a psychiatric condition with high morbidity, disability, suicide and recurrence rate and become the hot and difficult topics in the medical study. Given the unsatisf...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diagnostic criteria of CCMD-3 and DSM-4 depression;
- the score of PHQ-9 should be equal to or more than 15 points; the score of Hamilton Depression Rating Scale should be more than 18 points;
- without any drug treatment over the past 3 months
Exclusion
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04272476
Start Date
January 1 2014
End Date
December 1 2019
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan, China, 610000